Patients treated with ICIs alone ( n = 267) showed a trend toward longer PFS in the high ASV group compared with the low ASV group (median, 4.53 vs. 3.65 months; HR = 0.85; 95% CI, 0.65–1.13; Supplementary Fig.
← all excerpts
Microbiome Landscape and Association with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors: A SCRUM-Japan MONSTAR-SCREEN Study.
1
—
—